Type 2 diabetes and frequency of prevention and control measures

被引:30
|
作者
Jimenez-Corona, Aida [1 ]
Aguilar-Salinas, Carlos A. [2 ]
Rojas-Martinez, Rosalba [1 ]
Hernandez-Avila, Mauricio [1 ]
机构
[1] Inst Nacl Salud Publ, Cuernavaca 62100, Morelos, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
来源
SALUD PUBLICA DE MEXICO | 2013年 / 55卷
关键词
type 2 diabetes mellitus; primary prevention; quality of health care; Mexico; GLYCEMIC CONTROL; LATIN-AMERICA; HEALTH;
D O I
10.21149/spm.v55s2.5109
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. To determine the frequency of application of prevention and control measures for type 2 diabetes in Mexican population. Materials and methods. ENSANUT 2012 is a nationally and by-state representative survey. Sample design was probabilistic, multistage, stratified and clustered. The information of 46 277 adults >= 20 was used for this analysis. A weighted analysis was performed using Stata 12. Results. Prevalence of diabetes by previous diagnosis was 9.2% (6.4 millions) in ENSANUT 2012, 7.3% (3.7 millions) in 2006 and 4.6% (2.1 millions) in 2000. In 2012, the mean of medical examinations in the previous year related to diabetes control was 7.3. However, the percentage of cases in which preventive actions for chronic complications were performed (such as foot care [14.6%], ophthalmology [8.6%] and determination of HbA1c [9.6%]) was low. Conclusions. Patients with diabetes have frequent access to medical services. However, preventive actions are applied insufficiently both in quality and quantity.
引用
收藏
页码:S137 / S143
页数:7
相关论文
共 50 条
  • [31] Primary Prevention of Type 2 Diabetes
    Marrero, David G.
    Ackermann, Ronald T.
    Daly, Anne
    Hoskin, Mary
    Gallivan, Joanne
    Ruggiero, Laurie
    Kriska, Andrea
    DIABETES EDUCATOR, 2009, 35 : 57S - 59S
  • [32] Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran
    Molla, Ghasem Janbabaei
    Ismail-Beigi, Faramarz
    Larijani, Bagher
    Khaloo, Pegah
    Moosaie, Fatemeh
    Alemi, Hamid
    Mansournia, Mohammad Ali
    Ghadimi, Tayyeb
    Ghaemi, Fatemeh
    Nakhjavani, Manouchehr
    Esteghamati, Alireza
    CANADIAN JOURNAL OF DIABETES, 2020, 44 (03) : 246 - 252
  • [33] Prevention of type 2 diabetes mellitus
    Hauner, H
    Landgraf, R
    Schulze, J
    Spranger, J
    Standl, E
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (17) : 1053 - 1054
  • [34] Progress in the prevention of type 2 diabetes
    Schernthaner, G
    WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 (21-22) : 745 - 757
  • [35] Metformin for prevention of type 2 diabetes
    Hess, AM
    Sullivan, DL
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (7-8) : 1283 - 1285
  • [36] Strategies for the prevention of type 2 diabetes
    Pfohl, M
    Schatz, H
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 : S240 - S249
  • [37] The prevention of type 2 diabetes mellitus
    Davies, MJ
    CLINICAL MEDICINE, 2003, 3 (05) : 470 - 474
  • [38] Prevention of type 2 diabetes in childhood
    Cook, VV
    Hurley, JS
    CLINICAL PEDIATRICS, 1998, 37 (02) : 123 - 129
  • [39] Prevention of type 2 diabetes: An update
    Farag A.
    Karam J.
    Nicasio J.
    McFarlane S.I.
    Current Diabetes Reports, 2007, 7 (3) : 200 - 207
  • [40] Acarbose for type 2 diabetes prevention
    Scheen, AJ
    LANCET, 2002, 360 (9344): : 1516 - 1516